For example, in spitzoid melanoma patients, clinical sequencing uncovered such alterations in TPL2, which were mutually exclusive with alterations in other known driver oncogenes such as BRAF, NRAS, NTRK1/3, and ALK [100]. The gene discussed is MAP3K8; the disease is melanoma.